Apnimed (APMD) closed at $17.25 on November 19, 2026, down 1.2% from the previous close, on volume of 186,331 shares (30-day average 372,232).
Data as of November 19, 2026.
19-Nov-2026
New National Survey Found Many People With Sleep Apnea Struggle to Stay on Treatment
Globe Newswire (Thu, 19-Nov 8:00 AM ET)
Bank of America Securities Sticks to Its Buy Rating for Apnimed, Inc. (APMD)
TipRanks (Tue, 17-Nov 9:35 PM ET)
Apnimed, Inc. GAAP EPS of -$1.05 misses by $0.46
Seeking Alpha News (Mon, 16-Nov 10:38 AM ET)
Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Globe Newswire (Mon, 16-Nov 8:00 AM ET)
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Thu, 5-Nov 4:05 PM ET)
iOnctura appoints Paul Sekhri as Chair of its Board of Directors
Globe Newswire (Thu, 15-Oct 3:30 AM ET)
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
Globe Newswire (Mon, 12-Oct 4:05 PM ET)
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Globe Newswire (Tue, 8-Sep 4:39 PM ET)
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
Apnimed trades on the NASDAQ stock market under the symbol APMD.
As of November 19, 2026, APMD stock price declined to $17.25 with 186,331 million shares trading.
APMD has a beta of 1.81, meaning it tends to be more sensitive to market movements. APMD has a correlation of 0.05 to the broad based SPY ETF.
APMD has a market cap of $717.79 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that APMD belongs to (by Net Assets): IWM, VTI, VXF, IWO, VTWO.
APMD support price is $16.31 and resistance is $18.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APMD shares will trade within this expected range on the day.